纵横研报
Ticker Detail

603739.SHG

¥12.48+2.72% 蔚蓝生物 Biotechnology
00Reports China 医疗健康
Qingdao Vland Biotech Co Ltd
医疗健康 · 生物科技

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, food probiotics, environmental microorganisms, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated, and poultry and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antiviral, and nutritional drugs, as well as disinfectants; and traditional Chinese veterinary medicines for scale and avian breeding, livestock, and laying hens. It serves agriculture, animal husbandry, textile, pulp and paper, health care, laundry, biofuel, household cleaning and detergents, food, animal feed, biofuel, environmental protection, washing, and other industries. Qingdao Vland Biotech INC. was incorporated in 2005 and is headquartered in Qingdao, China.

MARKET 市值 3.00B CNY PE 38.2x 52W ¥11.18 – ¥18.41 EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG 营收 YoY 11.2% ROE 5.6% 营业利润率 8.3% 净利润率 5.6%
ANALYST 股息率 0.85%

暂无相关研报

数据库中已收录该标的的基本面数据,可发起一份定制研报。

CUSTOM RESEARCH · 定制研报 没找到完全契合的标的?让我们替你做一份。 告诉我们你关心的标的与偏好,1 个工作日内在站内上线。 开始定制